MX2012005013A - Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel. - Google Patents
Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel.Info
- Publication number
- MX2012005013A MX2012005013A MX2012005013A MX2012005013A MX2012005013A MX 2012005013 A MX2012005013 A MX 2012005013A MX 2012005013 A MX2012005013 A MX 2012005013A MX 2012005013 A MX2012005013 A MX 2012005013A MX 2012005013 A MX2012005013 A MX 2012005013A
- Authority
- MX
- Mexico
- Prior art keywords
- pter
- acceptable salt
- damages
- prevention
- skin diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
- C07C43/166—Unsaturated ethers containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
La presente invención se refiere al uso de PTER, o cualquiera de sus sales aceptables, opcionalmente, en combinación con QUER, o cualquiera de sus sales aceptables, para la fabricación de composiciones farmacéuticas para prevenir y/o tratar enfermedades, daños o lesiones de la piel. Esos procedimientos de prevención y/o tratamiento comprenden la administración de una cantidad eficaz de una composición que comprende PTER como compuesto activo, o cualquiera de sus sales aceptables, opcionalmente, en combinación con QUER, o cualquiera de sus sales aceptables, a un sujeto. La presente invención también se refiere a las composiciones, en sí, que comprenden PTER como compuesto activo, o cualquiera de sus sales aceptables, opcionalmente, en combinación con QUER, o cualquiera de sus sales aceptables, caracterizadas por estar formuladas en forma de liposomas, y al procedimiento para la preparación de dichas formulaciones en liposomas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09174717A EP2322159A1 (en) | 2009-10-30 | 2009-10-30 | Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic |
PCT/EP2010/066544 WO2011051483A1 (en) | 2009-10-30 | 2010-10-29 | Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012005013A true MX2012005013A (es) | 2012-08-15 |
Family
ID=42320589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012005013A MX2012005013A (es) | 2009-10-30 | 2010-10-29 | Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel. |
Country Status (14)
Country | Link |
---|---|
US (3) | US20130136778A1 (es) |
EP (2) | EP2322159A1 (es) |
JP (2) | JP2013509385A (es) |
KR (1) | KR101795495B1 (es) |
CN (1) | CN102639126B (es) |
AU (2) | AU2010311326B2 (es) |
BR (1) | BR112012010070A2 (es) |
CA (1) | CA2778151C (es) |
DK (1) | DK2493462T3 (es) |
ES (1) | ES2432236T3 (es) |
IL (1) | IL219318A (es) |
MX (1) | MX2012005013A (es) |
RU (1) | RU2578031C2 (es) |
WO (1) | WO2011051483A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9439875B2 (en) * | 2011-05-11 | 2016-09-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Anxiolytic effect of pterostilbene |
US8841350B2 (en) | 2011-05-11 | 2014-09-23 | ChromaDex Inc. | Method for inducing UDP-glucuronosyltransferase activity using pterostilbene |
JP5901547B2 (ja) * | 2012-03-28 | 2016-04-13 | 富士フイルム株式会社 | 組成物、これを含む皮膚外用剤、又は機能性食品 |
DK2705847T3 (da) * | 2012-09-05 | 2014-10-06 | Psoriasis & Creams Sweden Ab | Sammensætning til behandling af psoriasis |
CA2893342A1 (en) * | 2012-12-06 | 2014-06-12 | D & J Rosee Inc. | Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation |
CA2959756C (en) | 2014-09-04 | 2023-02-28 | The Regents Of The University Of California | Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin |
WO2016037007A1 (en) * | 2014-09-04 | 2016-03-10 | The Regents Of The University Of California | Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasia |
US11426398B2 (en) | 2015-06-10 | 2022-08-30 | Elysium Health, Inc. | Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders |
CN108653303A (zh) * | 2018-04-02 | 2018-10-16 | 青岛科技大学 | 一种具有提供弱酸性胶束微环境的高稳定型紫檀芪滴眼液及其制备方法 |
CN108653304A (zh) * | 2018-04-04 | 2018-10-16 | 青岛科技大学 | 一种紫檀芪纳米胶束外用凝胶及其制备方法 |
JP2020069470A (ja) * | 2018-10-29 | 2020-05-07 | 株式会社げんてん本店 | リポソームの製造方法、及び、リポソーム含有液の製造方法 |
KR20200052191A (ko) | 2018-11-06 | 2020-05-14 | 한국식품연구원 | 후각수용체 특이적 리간드 및 그 용도 |
WO2020263189A1 (en) * | 2019-06-25 | 2020-12-30 | Agency For Science, Technology And Research | Phenols that decrease lipid production in sebocytes |
JP7493176B2 (ja) | 2020-04-14 | 2024-05-31 | 国立研究開発法人産業技術総合研究所 | 放射線被ばくによる皮膚炎発生の予測 |
CN115040420A (zh) * | 2022-07-18 | 2022-09-13 | 云南贝泰妮生物科技集团股份有限公司 | 一种紫檀芪脂质体及其制备方法 |
US20240225980A9 (en) * | 2022-10-20 | 2024-07-11 | Innovation Hammer Llc | Methods and formulations for mitigating damaging effects from exposure to uv radiation |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5944313A (ja) * | 1982-09-07 | 1984-03-12 | Yakult Honsha Co Ltd | 抗菌性組成物 |
US5139803A (en) * | 1989-02-09 | 1992-08-18 | Nabisco, Inc. | Method and liposome composition for the stabilization of oxidizable substances |
AU2094901A (en) * | 1999-12-16 | 2001-06-25 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing a retinoid and a stilbene for skin care |
US20030105031A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Methods for the treatment of skin disorders |
DE10161253A1 (de) * | 2001-12-13 | 2003-06-26 | Dragoco Gerberding Co Ag | Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren |
CN1269782C (zh) * | 2003-10-24 | 2006-08-16 | 中国科学院广州化学研究所 | 紫檀芪的合成方法 |
ES2246165B1 (es) * | 2004-07-20 | 2006-12-01 | Universitat De Valencia | Uso combinado del pteroestilbeno y la quercetina para la fabricacion de medicamentos utiles en el tratamiento del cancer. |
US20060057231A1 (en) * | 2004-08-19 | 2006-03-16 | Rimando Agnes M | Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform |
US7776915B2 (en) | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
WO2008067928A1 (en) | 2006-12-04 | 2008-06-12 | Isdin S.A. | Uv absorbing compositions containing a pyrrolyltriazine |
US20090047309A1 (en) * | 2007-08-13 | 2009-02-19 | Maes Daniel H | Cosmetic methods and compositions for repairing human skin |
RU2357724C1 (ru) * | 2007-10-22 | 2009-06-10 | Институт химии нефти Сибирского отделения Российской академии наук | Способ получения магниточувствительных липосом |
WO2009082459A2 (en) * | 2007-12-24 | 2009-07-02 | Natrol, Inc. | Anti-aging composition containing resveratrol and method of administration |
US20100240767A1 (en) * | 2009-03-23 | 2010-09-23 | Muhammed Majeed | Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof |
CN101912377A (zh) * | 2010-08-10 | 2010-12-15 | 王晓琴 | 紫檀芪在制备抗***药物中的应用 |
-
2009
- 2009-10-30 EP EP09174717A patent/EP2322159A1/en not_active Withdrawn
-
2010
- 2010-10-29 AU AU2010311326A patent/AU2010311326B2/en not_active Ceased
- 2010-10-29 WO PCT/EP2010/066544 patent/WO2011051483A1/en active Application Filing
- 2010-10-29 ES ES10775793T patent/ES2432236T3/es active Active
- 2010-10-29 RU RU2012122241/15A patent/RU2578031C2/ru not_active IP Right Cessation
- 2010-10-29 EP EP10775793.2A patent/EP2493462B1/en active Active
- 2010-10-29 CA CA2778151A patent/CA2778151C/en not_active Expired - Fee Related
- 2010-10-29 JP JP2012535862A patent/JP2013509385A/ja active Pending
- 2010-10-29 DK DK10775793.2T patent/DK2493462T3/da active
- 2010-10-29 BR BR112012010070A patent/BR112012010070A2/pt not_active Application Discontinuation
- 2010-10-29 MX MX2012005013A patent/MX2012005013A/es active IP Right Grant
- 2010-10-29 US US13/504,056 patent/US20130136778A1/en not_active Abandoned
- 2010-10-29 CN CN201080048865.5A patent/CN102639126B/zh not_active Expired - Fee Related
- 2010-10-29 KR KR1020127013257A patent/KR101795495B1/ko active IP Right Grant
-
2012
- 2012-04-19 IL IL219318A patent/IL219318A/en not_active IP Right Cessation
-
2015
- 2015-07-09 JP JP2015138131A patent/JP5905979B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-10 US US15/041,013 patent/US20160158164A1/en not_active Abandoned
- 2016-09-29 AU AU2016234952A patent/AU2016234952B2/en not_active Ceased
-
2017
- 2017-07-26 US US15/660,844 patent/US20180008555A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20120094167A (ko) | 2012-08-23 |
BR112012010070A2 (pt) | 2016-05-31 |
EP2493462A1 (en) | 2012-09-05 |
JP2016006060A (ja) | 2016-01-14 |
AU2010311326B2 (en) | 2016-10-06 |
IL219318A (en) | 2016-03-31 |
AU2016234952B2 (en) | 2018-08-16 |
KR101795495B1 (ko) | 2017-12-01 |
US20130136778A1 (en) | 2013-05-30 |
EP2322159A1 (en) | 2011-05-18 |
JP2013509385A (ja) | 2013-03-14 |
WO2011051483A1 (en) | 2011-05-05 |
DK2493462T3 (da) | 2013-10-28 |
US20180008555A1 (en) | 2018-01-11 |
EP2493462B1 (en) | 2013-07-24 |
CN102639126A (zh) | 2012-08-15 |
RU2012122241A (ru) | 2013-12-10 |
CA2778151C (en) | 2017-03-07 |
RU2578031C2 (ru) | 2016-03-20 |
CA2778151A1 (en) | 2011-05-05 |
IL219318A0 (en) | 2012-06-28 |
CN102639126B (zh) | 2018-07-06 |
ES2432236T3 (es) | 2013-12-02 |
AU2010311326A1 (en) | 2012-05-17 |
AU2016234952A1 (en) | 2016-10-13 |
JP5905979B2 (ja) | 2016-04-20 |
US20160158164A1 (en) | 2016-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012005013A (es) | Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel. | |
MY185139A (en) | Substituted imidazopyridazines | |
MX369385B (es) | Productos para cicatrizar heridas tisulares. | |
WO2011139794A3 (en) | A composition for skin sanitization and protection and method of its use | |
MY168413A (en) | Amino-substituted imidazopyridazines | |
WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
WO2014099226A3 (en) | Personal cleansing compositions containing zinc amino acid/trimethylglycine halide | |
WO2013100567A8 (en) | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain | |
MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
EP2796450A4 (en) | 6-AMINOPYRIDINE-3-OL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES OR THESE SALTS AS ACTIVE INGREDIENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS DISEASES | |
PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
WO2012161497A3 (ko) | 보습능이 우수한 펩타이드 유도체 및 이의 용도 | |
EP4302825A3 (en) | Pharmaceutical compositions for treatment of inappetence | |
MX368880B (es) | Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal. | |
SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
TN2014000031A1 (en) | Use of organic compound for the treatment of noonan syndrome | |
WO2012106058A3 (en) | Animal treatments | |
WO2011058245A8 (fr) | Nouveaux derives de mannopyranoside ayant une activite anticancereuse | |
WO2014116015A3 (ko) | 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 | |
MY182553A (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
WO2010093615A3 (en) | Compounds, their syntheses, compositions, and methods to treat cancer | |
CR20130483A (es) | Combinaciones de principios activos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |